Study of Immune Deficiency Patients Treated With Subcutaneous Immunoglobulin (IgPro20, Hizentra®) on Weekly and Biweekly Schedules
Clinical trial NCT02711228 · COMPLETED
Trial details
- NCT number
- NCT02711228
- Sponsor
- CSL Behring
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-15
- Primary completion
- 2018-01-30
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.